Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Neurogene Inc NGNE

Healthcare Biotechnology
Neurogene Inc. is a clinical-stage biotechnology company. The Company, through its proprietary transgene regulation technology, Expression Attenuation via Construct Tuning (EXACT), is building a product portfolio of genetic medicines for rare neurological diseases with high unmet needs not otherwise addressable by conventional gene therapy. Its clinical-stage program, NGN-401, utilize the EXACT... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:NGNE)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE

PR Newswire 1 day ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE

Accesswire 2 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE

Accesswire 11 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE

Accesswire 12 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE

Accesswire 13 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE

Accesswire December 13, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE

Accesswire December 11, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE

PR Newswire December 3, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neurogene Inc. (NGNE) And Encourages Shareholders to Reach Out

Accesswire November 28, 2024
View More News ››

Opinion & Analysis (NDAQ:NGNE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NGNE)

Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Gr

Breaking News: $NGNE Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the...
whytestocks - November 26, 2024

Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc.

NEWS: $NGNE Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Shareholders to Inquire about Securities...
whytestocks - November 25, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigatio

Breaking News: $NGNE Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Neurogene Inc. (NGNE) and Encourages...
whytestocks - November 21, 2024

Bronstein, Gewirtz & Grossman, LLC Is Investigating Neurogen

JUST IN: $NGNE Bronstein, Gewirtz & Grossman, LLC Is Investigating Neurogene Inc. (NGNE) And Encourages Stockholders to ConnectNEW...
whytestocks - November 18, 2024

Neurogene Announces Oversubscribed $200 Million Private Plac

Breaking News: $NGNE Neurogene Announces Oversubscribed $200 Million Private PlacementFinancing included participation from top-tier...
whytestocks - November 4, 2024

NEUROGENE: A Promising Gene Therapy Company Advancing Innova

http://beyondspx.com/2024/08/02/neurogene-a-promising-gene-therapy-company-advancing-innovative-treatments-for-rare-neurological-diseases...
MikeTester - August 3, 2024
View more Bullboard ››

Riley Gold Corp.

Riley Gold Corp.

Riley Gold Corp. is a gold exploration company with projects within major gold bearing trends in the state of Nevada. The ...
View More »